OneSource Specialty Pharma Ltd. has been hit with a tax adjustment order of ₹425.95 million by tax authorities. The adjustment relates to differences found in the assessment of the company's financial and tax returns for a previous fiscal year.
Important facts:
-
The adjustment order may reflect on the company's finances for the current fiscal year.
-
OneSource said that it is analyzing the order and intends to pursue legal avenues to challenge or appeal the ruling if it deems it appropriate.
-
The firm is still dedicated to compliance and transparency in its financial activities.
The tax adjustment has arrived at a point when OneSource is adding new specialty pharma operations and will be influenced negatively by any form of financial tightening. Shareholders are warned to keep the progress under watch closely as the organization determines what moves to make.
Sources: on the basis of regulatory submissions of OneSource Specialty Pharma Ltd. to BSE, March 13, 2025